Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Pain Therapeutics (PTIE)

4.25 0.14 (3.41%)

12-12 10:35

Open:

4.16

Pre. Close:

4.11

High:

4.3244

Low:

4.16

Volume:

5,152

Market Cap:

28M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

4.37 - 4.43

4.43 - 4.48

Low:

3.98 - 4.04

4.04 - 4.09

Close:

4.1 - 4.19

4.19 - 4.29

Technical analysis  (as of: 2017-12-12 10:08:03 AM)

Overall:

      

Stoxline posted a BUY today, upgraded from lower rating. This stock seems to be ready for a new bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, a new upward move is expected.

Target:

Six months: 5.17     One year: 6.04

Support:

Support1: 3.84    Support2: 3.48

Resistance:

Resistance1: 4.43    Resistance2: 5.17

Pivot:

4.05

Moving Averages:

MA(5): 4.17     MA(20): 4.01

MA(100): 3.76     MA(250): 4.22

MACD:

MACD(12,26): 0.09     Signal(12,26,9): 0.06

%K %D:

%K(14,3): 68.78     %D(3): 66.41

RSI:

RSI(14): 61.44

52-Week:

High: 9.310009  Low: 3.1  Change(%): 3.9

Average Vol(K):

3-Month: 40889  10-Days 4415

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
PTIE has closed below upper band by 3.9%. Bollinger Bands are 31.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Mon, 30 Oct 2017 12:00:00 GMT
Pain Therapeutics Announces Upcoming Meeting with FDA

Mon, 18 Sep 2017 10:52:30 GMT
NIH Awards $1.8 Million Research Grant to Pain Therapeutics in Support of a ...

Tue, 12 Dec 2017 13:51:37 GMT
Reviewing Pain Therapeutics (PTIE) & Its Rivals

Mon, 11 Dec 2017 15:00:00 GMT
Equity Research Analyst's Stock Ratings: Novanta Inc. (NOVT), Pain ...

Tue, 12 Dec 2017 15:11:15 GMT
Pain Therapeutics, Inc. (NasdaqGS:PTIE) Enlivened Quant Data Under the Lens as ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

6.60

Shares Float (M)

4.92

% Held by Insiders

21.99

% Held by Institutions

36.16

Shares Short (K)

1150

Shares Short Prior Month (K)

893

Stock Financials

EPS

-1.870

EPS Est. Current Year

-2.350

EPS Est. Next Year

-2.600

EPS Est. Next Quarter

Forward EPS

-2.601

Book Value (p.s.)

1.720

PEG Ratio

-0.02

Profit Margin

Operating Margin

Return on Assets (ttm)

-43.3

Return on Equity (ttm)

-75.8

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-1.818

Qtrly Earnings Growth

Operating Cash Flow (M)

-9.83

Levered Free Cash Flow (M)

-5.40

atoplab.com

Valuation

P/E

-2.29

P/E Growth Ratio

0.03

P/BV

2.49

P/S

P/CF

-2.88

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

2012-12-24

Ex-Dividend Date

2012-12-13

Forward Dividend

Last Split Date

2017-05-10

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.